Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




C-Arm Accessory Reduces Fluoroscopic Radiation Exposure

By HospiMedica International staff writers
Posted on 01 Oct 2020
An innovative collimating system reduces unnecessary radiation exposure during fluoroscopically guided procedures, without compromising image quality in the region of interest (ROI).

The ControlRad (Peachtree Corners, GA, USA) Trace system is designed to help balance dose reduction with the need to visualize structures inside the ROI when considered clinically advantageous. More...
The resulting image has two parts: the unfiltered image inside the clinician-selected ROI, and the image outside the ROI, which has a lower-dose processed image, providing peripheral image context. Applications include vascular, cholangiography, endoscopic, urologic, orthopedic, neurologic, cardiac, critical care and emergency room procedures.

System components include the Trace Tablet, the Trace Filter, ControlRad Hardware, Software, and Firmware Modules, and the ControlRad communication interface. The Trace Tablet serves as operational control of the device via a graphical user interface (GUI) that enables the clinician to select the ROI. The semi-transparent Trace Filter reduces X-ray radiation outside the clinician-selected ROI, typically by 61% to 97%, and is installed on top of the C-arm’s collimator, and does not affect or modify its functionality.

The ControlRad Hardware, Software, and Firmware Modules control the Trace filter’s positioning, which is determined by the location of the clinician-selected ROI, and perform image processing. Finally, the ControlRad communication interface provides the data link between the various components of the ControlRad Trace Model 8 and the fluoroscopy system. The ControlRad Trace solution can be retrofitted onto existing mobile C-arms, reducing the barrier to technology adaptation.

“The ControlRad Trace system exceeded my expectations in reducing my radiation exposure, as well as the exposure to my patient and to my operating room team. There was no interruption of my normal workflow and zero loss to my image quality in the area where I was focused,” said orthopedic surgeon Andrew Cappuccino, MD, of Niagara Falls Memorial Medical Center (NY, USA). “I believe ControlRad Trace to be groundbreaking and one of the most important safety innovations that has been brought to market during my tenure as a surgeon.”

Related Links:
ControlRad


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Enteral Feeding Pump
SENTINELplus
Medical Monitor
VITALMAX 4100SL
Isolation Stretcher
IS 736
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.